[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.87.3. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Correspondence
November 2001

Cytoprotection Against Doxorubicin Toxicity

Arch Dermatol. 2001;137(11):1528. doi:

We read with interest the article by Lotem et al titled "Skin Toxic Effects of Polyethylene Glycol–Coated Liposomal Doxorubicin" in the ARCHIVES.1 We write to suggest that it may be possible to partially protect against the mucocutaneous toxicity of polyethylene glycol–coated liposomal doxorubicin hydrochloride (Doxil) in cancer-treated patients with the use of cytoprotective prostaglandins.

First Page Preview View Large
First page PDF preview
First page PDF preview
×